Genetic Testing is Superior Over Endogenous Pharmacometabolomic Markers to Predict Safety of Haloperidol in Patients with Alcohol-induced Psychotic Disorder

DSpace Repository

Genetic Testing is Superior Over Endogenous Pharmacometabolomic Markers to Predict Safety of Haloperidol in Patients with Alcohol-induced Psychotic Disorder

Author: Skryabin, Valentin; Zastrozhin, Mikhail; Parkhomenko, Alexandra; Lauschke, Volker M.; Smirnov, Valery; Petukhov, Aleksey; Pankratenko, Elena; Pozdnyakov, Sergei; Koporov, Sergei; Denisenko, Natalia; Akmalova, Kristina; Bryun, Evgeny; Sychev, Dmitry
Tübinger Autor(en):
Lauschke, Volker M.
Published in: Current Drug Metabolism (2022), Bd. 23, H. 13, S. 1067-1071
Verlagsangabe: Sharjah : Bentham Science Publ Ltd
Language: English
Full text: http://dx.doi.org/10.2174/1389200224666221228112643
ISSN: 1389-2002
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)